ArticleJournal of experimental & clinical cancer research : CR2018

Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling.

Shijian Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.